A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design

被引:56
作者
Jauffret-Roustide, Marie [1 ,2 ]
Le Strat, Yann [1 ]
Couturier, Elisabeth [1 ]
Thierry, Damien [3 ,4 ]
Rondy, Marc [2 ]
Quaglia, Martine [5 ]
Razafandratsima, Nicolas [5 ]
Emmanuelli, Julien [1 ]
Guibert, Gaelle [2 ]
Barin, Francis [3 ,4 ]
Desenclos, Jean-Claude [1 ]
机构
[1] Natl Inst Publ Hlth Surveillance, Dept Infect Dis, St Maurice, France
[2] Univ Paris 05, INSERM, UMR CNRS 8136, Ctr Res Psychotrop Hlth Mental Hlth & Soc,U611, Paris, France
[3] Univ Tours, INSERM, ERI 19, Tours, France
[4] CHU Bretonneau, Natl Reference Ctr HIV, F-37044 Tours, France
[5] Natl Inst Demog Studies, Paris, France
关键词
HEPATITIS-C-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; RISK-FACTORS; HARM-REDUCTION; HIV-INFECTION; SUBSTANCE USE; B-VIRUS; INJECTION; PREVALENCE; COHORT;
D O I
10.1186/1471-2334-9-113
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Epidemiology of HCV infection among drug users (DUs) has been widely studied. Prevalence and sociobehavioural data among DUs are therefore available in most countries but no study has taken into account in the sampling weights one important aspect of the way of life of DUs, namely that they can use one or more specialized services during the study period. In 2004-2005, we conducted a national seroepidemiologic survey of DUs, based on a random sampling design using the Generalised Weight Share Method (GWSM) and on blood testing. Methods: A cross-sectional multicenter survey was done among DUs having injected or snorted drugs at least once in their life. We conducted a two stage random survey of DUs selected to represent the diversity of drug use. The fact that DUs can use more than one structure during the study period has an impact on their inclusion probabilities. To calculate a correct sampling weight, we used the GWSM. A sociobehavioral questionnaire was administered by interviewers. Selected DUs were asked to self-collect a fingerprick blood sample on blotting paper. Results: Of all DUs selected, 1462 (75%) accepted to participate. HCV seroprevalence was 59.8% [95% CI: 50.7-68.3]. Of DUs under 30 years, 28% were HCV seropositive. Of HCV-infected DUs, 27% were unaware of their status. In the month prior to interview, 13% of DUs shared a syringe, 38% other injection parapharnelia and 81% shared a crack pipe. In multivariate analysis, factors independently associated with HCV seropositivity were age over 30, HIV seropositivity, having ever injected drugs, opiate substitution treatment (OST), crack use, and precarious housing. Conclusion: This is the first time that blood testing combined to GWSM is applied to a DUs population, which improve the estimate of HCV prevalence. HCV seroprevalence is high, indeed by the youngest DUs. And a large proportion of DUs are not aware of their status. Our multivariate analysis identifies risk factors such as crack consumption and unstable housing.
引用
收藏
页数:12
相关论文
共 74 条
[11]   Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City [J].
Des Jarlais, DC ;
Diaz, T ;
Perlis, T ;
Vlahov, D ;
Maslow, C ;
Latka, M ;
Rockwell, R ;
Edwards, V ;
Friedman, SR ;
Monterroso, E ;
Williams, I ;
Garfein, RS .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (05) :467-471
[12]  
Des Jarlais DC, 1999, PUBLIC HEALTH, V113, P182
[13]  
Diaz T, 2001, AM J PUBLIC HEALTH, V91, P23, DOI 10.2105/AJPH.91.1.23
[14]   Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003 [J].
Emmanuelli, J ;
Desenclos, JC .
ADDICTION, 2005, 100 (11) :1690-1700
[15]   Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study) [J].
Evans, JL ;
Hahn, JA ;
Page-Shafer, K ;
Lum, PJ ;
Stein, ES ;
Davidson, PJ ;
Moss, AR .
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2003, 80 (01) :137-146
[16]   Crack cocaine smoking and oral sores in three inner-city neighborhoods [J].
Faruque, S ;
Edlin, BR ;
McCoy, CB ;
Word, CO ;
Larsen, SA ;
Schmid, DS ;
VonBargen, JC ;
Serrano, Y .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 (01) :87-92
[17]   Factors associated with HIV/AIDS high-risk behaviours among female injection drug users [J].
Fitzgerald, T. ;
Lundgren, L. ;
Chassler, D. .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2007, 19 (01) :67-74
[18]  
Foley D, 1998, Body Posit, V11, P35
[19]   Hepatitis C incidence - a comparison between injection and noninjection drug users in New York city [J].
Fuller, CM ;
Ompad, DC ;
Galea, S ;
Wu, YF ;
Koblin, B ;
Vlahov, D .
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2004, 81 (01) :20-24
[20]   Social circumstances of initiation of injection drug use and early shooting gallery attendance: Implications for HIV intervention among adolescent and young adult injection drug users [J].
Fuller, CM ;
Vlahov, D ;
Latkin, CA ;
Ompad, DC ;
Celentano, DD ;
Strathdee, SA .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (01) :86-93